НовостиBenzingaRBC Capital Maintains Outperform on Definium Therapeutics, Raises Price Target to $70 RBC Capital Maintains Outperform on Definium Therapeutics, Raises Price Target to $70 Benzinga 2026.11.10 15:59 (GMT+0) Открыть на Benzinga Другие новости